Jane Street’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,581
Closed -$109K 12226
2025
Q4
$130K Buy
32,581
+22,308
+217% +$98.7K ﹤0.01% 10039
2025
Q3
$38.8K Buy
+10,273
New +$34.9K ﹤0.01% 10408
2023
Q4
Sell
-127,241
Closed -$168K 9483
2023
Q3
$168K Buy
+127,241
New +$279K ﹤0.01% 7729
2023
Q2
Sell
-25,319
Closed -$87.6K 9097
2023
Q1
$87.6K Sell
25,319
-48,353
-66% -$234K ﹤0.01% 8284
2022
Q4
$308K Buy
+73,672
New +$279K ﹤0.01% 6973
2022
Q2
Sell
-14,571
Closed -$236K 10186
2022
Q1
$236K Buy
+14,571
New +$373K ﹤0.01% 8784
2021
Q4
Sell
-152,843
Closed -$9.17M 10420
2021
Q3
$11.1M Buy
152,843
+134,977
+755% +$9.76M ﹤0.01% 1684
2021
Q2
$1.5M Buy
+17,866
New +$1.18M ﹤0.01% 4933
2021
Q1
Sell
-8,634
Closed -$407K 9338
2020
Q4
$407K Buy
+8,634
New +$340K ﹤0.01% 6015

Other funds holding NBP

Jane Street's NBP Position: Q1 2026 in Review

Jane Street sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 32,581 shares — an estimated $109K sold.

Jane Street first reported a position in NBP in Q4 2020 and held it in 9 quarters. The position peaked at $11.1M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Jane Street reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 32,581 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $109K.
  • Jane Street first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 9 quarters.
  • Jane Street's NovaBridge Biosciences American Depositary Shares position peaked at $11.1M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.